
KURA’s latest rating updates from top analysts.
In a filing, Kura Oncology Inc revealed its President and CEO WILSON TROY EDWARD acquired Company’s shares for reported $0.21
In a filing, Kura Oncology Inc revealed its President and CEO WILSON TROY EDWARD acquired Company’s shares for reported $0.21
Kura Oncology Inc’s recently made public that its President and CEO WILSON TROY EDWARD acquired Company’s shares for reported $0.21
Kura Oncology Inc’s recent filing unveils that its President and CEO WILSON TROY EDWARD acquired Company’s shares for reported $0.21
Kura Oncology Inc’s recently made public that its President and CEO WILSON TROY EDWARD acquired Company’s shares for reported $0.21
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Kura Oncology Inc’s recently made public that its Chief Legal Officer Bair Teresa Brophy unloaded Company’s shares for reported $9292.0
Kura Oncology Inc’s recent filing unveils that its Chief Legal Officer Bair Teresa Brophy unloaded Company’s shares for reported $9292.0